Later on, the compound, together with other modest molecules, was screened for more development by Hungarian business Biorex, which was bought to CytRx Corporation, who developed it toward another route from 2003. Name your selection: Name needs to be below characters Select a group: Not able to load your selection https://oswaldw689vto9.wikilima.com/user